KIIL HARRY SKIP
EVP & President Cardiovascular
KIIL HARRY SKIP has filed 8 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, KIIL HARRY SKIP is listed as EVP & President Cardiovascular at Medtronic plc. Inside the rolling window, KIIL HARRY SKIP reported no open-market purchases and 3 open-market sales totaling $5.6M in MDT. The largest disclosed transaction in the window is a sale of 52,524 MDT shares on Feb 19, 2026, worth $5.1M.
Companies traded
Other insiders at MDT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has KIIL HARRY SKIP made?
KIIL HARRY SKIP has filed 8 SEC Form 4 filings (18 transaction rows) across 1 company since 2025.
Which companies does KIIL HARRY SKIP trade?
KIIL HARRY SKIP has filed SEC Form 4 disclosures for 1 company, including MDT.
When was KIIL HARRY SKIP's most recent SEC Form 4 filing?
KIIL HARRY SKIP's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is KIIL HARRY SKIP's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, KIIL HARRY SKIP is listed as EVP & President Cardiovascular.
What is KIIL HARRY SKIP's total buy and sell value in the current window?
Inside the rolling retention window, KIIL HARRY SKIP bought $0 and sold $5.6M based on SEC Form 4 filings.
What was KIIL HARRY SKIP's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 52,524 MDT shares on 2026-02-19, worth $5.1M, per SEC Form 4 filings.